Cite
HARVARD Citation
Bergvall, N. et al. (2014). Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis. Journal of medical economics. pp. 696-707. [Online].